The Versius trial is focusing on children and infants that are undergoing a range of urological procedures.

Moore brings more than 35 years of experience in the medtech industry, including nearly 20 years spent at Boston Scientific, to CMR Surgical.

Surgical robots are gaining popularity due to AI adoption, remote control, and startup competition, with 2024 expected to be a significant year for the sector.

CMR Surgical’s vLimeLite system is designed to enhance visual assessment of the vessels and blood flow for surgeons.

Over the past year, CMR Surgical has moved forward on several vital initiatives to set itself up for success.

Here is a list of 10 surgical robotics companies that continue to attract attention from our editors and audience.

CMR Surgical plans to launch new advanced technologies to further support the utilization of Versius in 2024.

CMR Surgical announced today that it raised a funding round worth $165 million (£133 million) and hit a milestone with its surgical robot.

Johnson & Johnson’s Ethicon business unit will sell CMR’s surgical robotics system to select hospitals in Italy, France, Germany and Brazil.

There are now Versius robots in operation across Europe, Asia, Australia, Latin America, and the Middle East.

CMR Surgical has now raised nearly $1 billion since it was founded in 2014.

In September 2019, the biggest robotics deals were in healthcare, followed by self-driving cars and service robots.

Cambridge, U.K.-based CMR Surgical raised a $240 million Series C round for its Versius surgical robot. CMR Surgical said it will use the funding to launch the Versius surgical robot “imminently” in Europe and Asia, with “further international expansion expected thereafter.” The Series C round included existing backers LGT Lightstone, Escala Capital Investments, Cambridge Innovation…